Danske Bank’s Purple Biotech PPBT Stock Holding History

Danske Bank’s Portfolio PPBT Stock Details PPBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4	Closed	-$16	–	1203
2026 Q1	$16	Buy	+4	New	+$22	﹤0.01%	1076
2024 Q4	–	Hold	0	–	-$22	–	1596
2024 Q3	–	Hold	0	–	–	–	1498

Other funds holding PPBT

SmartHarvest Portfolios Poulsbo, Washington $309M AUM

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

IAA

Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

Danske Bank's PPBT Position: Q2 2026 in Review

Danske Bank sold out of Purple Biotech (PPBT) in Q2 2026, closing a stake of 4 shares — an estimated $16 sold.

Danske Bank first reported a position in PPBT in Q1 2026 and held it in 1 quarter. The position peaked at $16 in Q1 2026. 13 funds tracked by Wall St. Rank hold PPBT as of Q2 2026.

Danske Bank reported no remaining Purple Biotech position as of Q2 2026 after selling out during the quarter.
Danske Bank sold 4 Purple Biotech shares in Q2 2026, an estimated $16.
Danske Bank first reported a position in Purple Biotech in Q1 2026 and held it in 1 quarter.
Danske Bank's Purple Biotech position peaked at $16 in Q1 2026.
13 funds tracked by Wall St. Rank held Purple Biotech as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.